---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-269559"
form_type: "8-K"
ticker: "DH"
cik: "0001861795"
company_name: "Definitive Healthcare Corp."
filed_at: "2025-11-06T23:59:59+00:00"
generated_at: "2026-05-17T00:00:50.488601+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Definitive Healthcare Q3 revenue $60M (-4% YoY); net loss $17.8M; raises FY revenue guidance low end

## Summary
- Revenue $60.0M (-4% vs $62.7M in Q3 2024); net loss $17.8M (vs $187.8M including $228.2M goodwill impairment).
- Adjusted EBITDA $18.9M (32% margin), down from $20.6M (33% margin) YoY; adjusted net income $9.7M.
- Q4 2025 revenue guidance $59-60M; FY 2025 revenue guidance raised to $239-240M (low end up $2M).
- Customer wins: large biopharma and medical device company selected Definitive Healthcare for commercial intelligence.
- Cash flow from operations $15.7M; unlevered free cash flow $17.9M in Q3 2025.

## SEC filing metadata
- accession: 0001193125-25-269559
- form_type: 8-K
- ticker: DH
- cik: 0001861795
- company_name: Definitive Healthcare Corp.
- filed_at: 2025-11-06T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1861795/000119312525269559/0001193125-25-269559-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1861795/000119312525269559/dh-20251106.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-269559
- JSON: https://secwatch.observer/filing/0001193125-25-269559.json
- Plain text: https://secwatch.observer/filing/0001193125-25-269559.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.